Literature DB >> 21939402

Some patient-related factors associated with late access to ART in China's free ART program.

Yi Wen1, Decai Zhao, Zhihui Dou, Ye Ma, Yan Zhao, Lin Lu, Wei Liu, Hao Zhu, Fujie Zhang.   

Abstract

Highly active antiretroviral therapy (HAART) has become widely available in China during the past seven years. However, many patients still initiate treatment at very late stages. To understand the distribution of baseline CD4 and factors associated with late antiretroviral therapy (ART) access, the National Free ART Database was retrospectively reviewed and a total of 49,321 HIV/AIDS patients were identified in this study based on the following inclusion criteria: (1) age ≥18; (2) initiated HAART between 1 July, 2006 and 31 December, 2009; (3) have recorded baseline CD4 cell count. This study showed that although both the median and mean baseline CD4 increased consistently over the study period, there were still about 30% of HIV/AIDS patients accessing ART at a very late stage (CD4 ≤ 50 µl) in 2009. Risk factors for late ART access included being male, single, having a short time interval between HIV diagnosis and treatment, and being infected through heterosexual contact. Being infected through injection drug use and homosexual contact were protective. Transmission route and marriage status showed different effects in a gender stratified analysis. A strengthened HIV testing and screening program is the key to improving the accessibility of ART and populations that are vulnerable to sexual transmission of HIV should be the primary target of the program.

Entities:  

Mesh:

Year:  2011        PMID: 21939402     DOI: 10.1080/09540121.2011.555748

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  8 in total

1.  Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.

Authors:  Man Po Lee; Jialun Zhou; Liesl Messerschmidt; Miwako Honda; Rossana Ditangco; Thira Sirisanthana; Nagalingeswaran Kumarasamy; Praphan Phanuphak; Yi-Ming Arthur Chen; Fujie Zhang; Vonthanak Saphonn; Sasisopin Kiertiburanakul; Christopher K C Lee; Sanjay Pujari; Jun Yong Choi; Adeeba Kamarulzaman; Evy Yunihastuti; Tuti Parwati Merati; Poh-Lian Lim; Patrick C K Li
Journal:  AIDS Patient Care STDS       Date:  2015-03-16       Impact factor: 5.078

2.  HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China.

Authors:  Yi Wen; Yun Shi; Chengqin Jiang; Roger Detels; Di Wu
Journal:  AIDS Care       Date:  2012-10-15

3.  Baseline CD4 cell counts of newly diagnosed HIV cases in China: 2006-2012.

Authors:  Houlin Tang; Yurong Mao; Cynthia X Shi; Jing Han; Liyan Wang; Juan Xu; Qianqian Qin; Roger Detels; Zunyou Wu
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

4.  Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.

Authors:  Wei Cheng; Yasong Wu; Yi Wen; Ye Ma; Decai Zhao; Zhihui Dou; Weiwei Zhang; Marc Bulterys; Fujie Zhang
Journal:  Bull World Health Organ       Date:  2015-01-29       Impact factor: 9.408

5.  Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.

Authors:  Jianjun Sun; Li Liu; Jiayin Shen; Panpan Chen; Hongzhou Lu
Journal:  BMC Infect Dis       Date:  2017-04-19       Impact factor: 3.090

6.  HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China.

Authors:  Ying-Hua Xia; Megan M McLaughlin; Wen Chen; Li Ling; Joseph D Tucker
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

7.  The increased effectiveness of HIV preventive intervention among men who have sex with men and of follow-up care for people living with HIV after 'task-shifting' to community-based organizations: a 'cash on service delivery' model in China.

Authors:  Hongjing Yan; Min Zhang; Jinkou Zhao; Xiping Huan; Jianping Ding; Susu Wu; Chenchen Wang; Yuanyuan Xu; Li Liu; Fei Xu; Haitao Yang
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

8.  Addressing injecting drug use in Asia and Eastern Europe.

Authors:  Zunyou Wu; Cynthia X Shi; Roger Detels
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.